Cite
HARVARD Citation
Fernández, O. et al. (2020). Comparison of first-line and second-line use of fingolimod in relapsing MS: The open-label EARLIMS study. Multiple sclerosis journal, experimental, translational and clinical. 6 (3), p. . [Online].